Neoadjuvant Chemotherapy and Radiotherapy in Locally Advanced Rectal Carcinoma

1-ChungM,LeeJ,TerasawaT. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:82 “Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix:  a basis for checklists. Cancer Committee,” Archives of Pathology and Laboratory Medicine, vol. 124, no. 7, pp. 1016–1025, 2000.

 2- Tørring ML, Frydenberg M, Hansen RP. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer 2011; 104:934.

3-Cao S, Bhattacharya A, Durrani FA, Fakih M. Irinotecan, oxaliplatin and raltitrexed for the   treatment of advanced colorectal cancer. Expert Opinion on Pharmacotherapy. 2006.

4-Capirci C., Valentini V., Cionini L., De Paoli A., Rodel C., Glynne-Jones R., Coco C.,Romano M., Mantello G., Palazzi S., Osti M.F., Friso M.L., Genovesi D., Vidali C.,Gambacorta M.A., Buffoli A., Lupattelli M., Favretto M.S. & LaTorre G. (2008)Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients. Int J Radiat Biol Phys; 72:99-107.     

5-Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2009 Jan 21. CD006041

6-Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010 Nov 1. 28(31):4697-705. [Medline].          

7-Jakobsen A, Ploen J, Vuong T, Appelt A, Lindebjerg J, Rafaelsen SR. Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer: A Randomized Trial Comparing Two Radiation Doses. Int J Radiat Oncol Biol Phys. 2012 May 15.

8-Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001 Aug 30. 345(9):638-46.           

9-Kidwell KM, Yothers G, Ganz PA, Land SR, Ko CY, Cecchini RS. Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from

10-Maurer CA, Renzulli P, Kull C. The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results. Ann Surg Oncol. 2011 Jul. 18(7):1899-906.   

11-Torre LA, Bray F, Siegel RL. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87           

12-Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev. 2007 Apr 18. CD002102.

13-Lemmens V, Steenbergen LV, Janssenheijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975-2007: Rectal cancer survival levels with colon cancer survival. Acta Oncol. 2010;49:784–96. [PubMed]

14- Glimelius B, editor Multidisciplinary treatment of patients with rectal cancer. Development during the past decades and plans for the future. Mechatronics and Automation (ICMA), 2012 International Conference on; 2012. [PMC free article] [PubMed

15- Belluco C, Paoli AD, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A. et al. Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies. Ann Surg Oncol. 2011;18:3686–93. [PMC free article] [PubMed]

16- Gerard JP, Francois Y, Nemoz C, Adeleine P. 55 Influence of the interval between pre-operative radiotherapy (preop-XRT) and surgery on the downstaging . 17-Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM. et al. Metformin use and improved response to therapy in rectal cancer. Cancer Medicine. 2013;2:99–107. [PMC free article] [PubMed]

18-Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: Controversies and questions. World J Gastroenterol. 2012;18:5521–32. [PMC free article] [PubMed].

19- Zhao HC, Gao C. Evaluation criteria of the efficacy of neoadjuvant therapy for colorectal cancer. J Digest Dis. 2011;31:253–255.

20- Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T. et al. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Medical Science Monitor International Medical Journal of Experimental & Clinical Research. 2010;16:19–30. [PubMed]

21- Kekelidze M, D'Errico L, Pansini M, Tyndall A, Hohmann J. Colorectal cancer:Current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol. 2013;19:8502–14. [PMC free article] [PubMed].

22-Hwang K, Park IJ, Chang SY, Lim SB, Lee JL, Yong SY, Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer. World J Gastroenterology; 2015. pp. 555–62. [PMC free article] [PubMed]

23- Brændengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L. et al. Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. J Clinical Oncology. 2008;26:3687–94. [PubMed]